Does MOMETASONE FUROATE Cause Nasal polyps? 284 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 284 reports of Nasal polyps have been filed in association with MOMETASONE FUROATE (Mometasone Furoate). This represents 2.4% of all adverse event reports for MOMETASONE FUROATE.
284
Reports of Nasal polyps with MOMETASONE FUROATE
2.4%
of all MOMETASONE FUROATE reports
0
Deaths
146
Hospitalizations
How Dangerous Is Nasal polyps From MOMETASONE FUROATE?
Of the 284 reports, 146 (51.4%) required hospitalization, and 11 (3.9%) were considered life-threatening.
Is Nasal polyps Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMETASONE FUROATE. However, 284 reports have been filed with the FAERS database.
What Other Side Effects Does MOMETASONE FUROATE Cause?
No adverse event (3,717)
Product quality issue (3,406)
Poor quality device used (2,159)
Drug dose omission (2,005)
Dyspnoea (1,522)
Device malfunction (1,332)
Asthma (1,307)
Wheezing (1,142)
Cough (1,052)
Gastrooesophageal reflux disease (1,029)
What Other Drugs Cause Nasal polyps?
DUPILUMAB (1,391)
ALBUTEROL (915)
PREDNISONE (780)
MEPOLIZUMAB (702)
MONTELUKAST (622)
OMALIZUMAB (544)
BUDESONIDE\FORMOTEROL (486)
TIOTROPIUM (400)
BUDESONIDE (397)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (311)
Which MOMETASONE FUROATE Alternatives Have Lower Nasal polyps Risk?
MOMETASONE FUROATE vs MOMETASONE FUROATE\OLOPATADINE
MOMETASONE FUROATE vs MONOMETHYL
MOMETASONE FUROATE vs MONTELUKAST
MOMETASONE FUROATE vs MONTELUKAST\MONTELUKAST
MOMETASONE FUROATE vs MONTMORILLONITE